Tikun Olam-Cannbit Pharmaceuticals Ltd (TKUNF)

Market Cap	3.31M -58.3%
Revenue (ttm)	2.86M -79.0%
Net Income	-4.97M
EPS	-5.85
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	6.00
Previous Close	6.00
Day's Range	6.00 - 6.00
52-Week Range	0.06 - 600.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 21, 2026

About TKUNF

Tikun Olam-Cannbit Pharmaceuticals Ltd engages in the production, supply, and marketing of cannabis-based products for medical use in Israel. The company offers cannabis-based products in form of inflorescences, medical cannabis oils based on medical cannabis strains, and based on cannabis strains. It also sells medical cannabis products for the treatment and relief of symptoms for various of medical indications. Tikun Olam-Cannbit Pharmaceuticals Ltd was incorporated in 1995 and is based in Nof HaGalil, Israel.

• Industry: Pharmaceutical Preparations
• Founded: 1995
• Employees: 4
• Stock Exchange: OTCMKTS
• Ticker Symbol: TKUNF

Financial Performance

In 2025, TKUNF's revenue was 9.10 million, a decrease of -73.96% compared to the previous year's 34.95 million. Losses were -15.85 million, -60.47% less than in 2024.

Financial numbers in ILS

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Jun 26, 2026

Data Sources Report a data error